In light of litifilimab recently receiving FDA Breakthrough Therapy Designation for CLE, we spoke with experts to discuss diagnostic and treatment gaps in disease management.

Our most recent episode of The Expert Series podcast “Your Lupus Treatment Roadmap: Understanding the New Guidelines and What They Mean for You” explores the newly released SLE treatment guidelines ...

Nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a potential treatment for adults with systemic lupus erythematosus (SLE). Fast Track designation is designed to ...

Phase 3 trial data show that obinutuzumab significantly reduces disease activity in very active extrarenal lupus.

Please provide your email address to receive an email when new articles are posted on . Victoria P. Werth, MD, professor of dermatology at the University of Pennsylvania Hospital, and chief of ...

More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant improvement in their symptoms after a year on the drug, researchers reported March 6 in The New England ...

Roche has received FDA approval for its antibody treatment Gazyva to be used in combination with standard therapy for adults with active lupus nephritis. Lupus nephritis affects more than 1.7 million ...

Add Yahoo as a preferred source to see more of our stories on Google. Dealing with unexplained symptoms when you’re undergoing treatment for lupus can make you question what’s going on in your body.

Doctor after doctor misdiagnosed or shrugged off Ruth Wilson’s rashes, swelling, fevers, and severe pain for six years. She saved her life by begging for one more test in an emergency room about to ...

Add Yahoo as a preferred source to see more of our stories on Google. For many women living with lupus, the hardest part of the disease isn’t learning the diagnosis, it’s learning how much suffering ...